GGN Promotes Tumorigenesis by Regulating Proliferation and Apoptosis in Colorectal Cancer

  • Zheng Liu
  • Ming Yang
  • Song Wang
  • Hai-peng Chen
  • Xu Guan
  • Zhi-xun Zhao
  • Zheng Jiang
  • Ji-chuan Quan
  • Run-kun Yang
  • Xi-shan WangEmail author
Original Article


Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. GGN is a germ cell-specific gene, but its function in CRC has been rarely reported to date. The aim of this study was to investigate the potential role of GGN in CRC tumorigenesis. Therefore, in this study, we examined the expression of GGN in CRC cell lines and tissues and its effects on cellular proliferation and apoptosis. We then explored the underlying mechanism. Our results showed that GGN was significantly overexpressed in both CRC cell lines and tissues. Silencing GGN robustly inhibited proliferation of CRC cells, and it also promoted apoptosis of CRC cells. Moreover, knockdown of GGN inhibited the expression of p-Akt in CRC cells. Taken together, these results showed that knockdown of GGN inhibits proliferation and promotes apoptosis of CRC cells through the PI3K/Akt signaling pathway. Our findings revealed for the first time a potential oncogenic role for GGN in CRC progress. This finding may provide a unique perspective on how a germ cell-specific gene might serve as a biomarker, or even as a therapeutic target, for CRC.


Colorectal cancer Gametogenetin (GGNProliferation Apoptosis 



This study was supported by the Beijing Municipal Science & Technology Commission (No. Z161100000116090); the National Key Research and Development Program of the Ministry of Science and Technology of China (No. 2016YFC0905303); the CAMS Innovation Fund for Medical Sciences (CIFMS) (No.2016-I2M-1-001); and the Beijing Science and Technology Program (No. D17110002617004).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRefGoogle Scholar
  2. 2.
    Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRefGoogle Scholar
  3. 3.
    Kuipers EJ, Grady WM, Lieberman D et al (2015) Colorectal cancer. Nat Rev Dis Primers 1:15065CrossRefGoogle Scholar
  4. 4.
    Fakih MG (2015) Metastatic colorectal cancer: current state and future directions. J Clin Oncol 33:1809–1824CrossRefGoogle Scholar
  5. 5.
    Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490–1502CrossRefGoogle Scholar
  6. 6.
    Colussi D, Brandi G, Bazzoli F, Ricciardiello L (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14:16365–16385CrossRefGoogle Scholar
  7. 7.
    Johnston PG (2014) Identification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era. Oncologist 19:568–573CrossRefGoogle Scholar
  8. 8.
    Lu B, Bishop CE (2003) Mouse GGN1 and GGN3, two germ cell-specific proteins from the single gene GGN, interact with mouse POG and play a role in spermatogenesis. J Biol Chem 278:16289–16296CrossRefGoogle Scholar
  9. 9.
    Jamsai D, Sarraj MA, Merriner DJ, Drummond AE, Jones KT, McLachlan RI, O’Bryan MK (2011) GGN1 in the testis and ovary and its variance within the Australian fertile and infertile male population. Int J Androl 34:624–632CrossRefGoogle Scholar
  10. 10.
    Wang W, Li C, Chen Y, Teng L, Cao Y, Xu Y, Pan H, An R (2018) Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis. Gene 652:7–15CrossRefGoogle Scholar
  11. 11.
    Lan ZJ, Hu Y, Zhang S, Li X, Zhou H, Ding J, Klinge CM, Radde BN, Cooney AJ, Zhang J, Lei Z (2016) GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells. Breast Cancer Res Treat 158:263–276CrossRefGoogle Scholar
  12. 12.
    Yin F, Liu L, Liu X et al (2014) Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer. Oncol Rep 32:362–372CrossRefGoogle Scholar
  13. 13.
    Tariq K, Ghias K (2016) Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med 13:120–135CrossRefGoogle Scholar
  14. 14.
    Okugawa Y, Grady WM, Goel A (2015) Epigenetic alterations in colorectal Cancer: emerging biomarkers. Gastroenterology 149:1204–1225.e12CrossRefGoogle Scholar
  15. 15.
    Chen A, Li J, Song L, Ji C, Böing M, Chen J, Brand-Saberi B (2017) GGNBP2 is necessary for testis morphology and sperm development. Sci Rep 7:2998CrossRefGoogle Scholar
  16. 16.
    Zhao Q, Zhou Y, Cao Z, Zhu H, Huang P, Lu B (2005) Germ-cell specific protein gametogenetin protein 2 (GGN2), expression in the testis, and association with intracellular membrane. Mol Reprod Dev 72:31–39CrossRefGoogle Scholar
  17. 17.
    Stoian M, State N, Stoica V, Radulian G (2014) Apoptosis in colorectal cancer. J Med Life 7:160–164Google Scholar
  18. 18.
    Galluzzi L, López-Soto A, Kumar S, Kroemer G (2016) Caspases connect cell-death signaling to organismal homeostasis. Immunity 44:221–231CrossRefGoogle Scholar
  19. 19.
    Malinowsky K, Nitsche U, Janssen KP, Bader FG, Späth C, Drecoll E, Keller G, Höfler H, Slotta-Huspenina J, Becker KF (2014) Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br J Cancer 110:2081–2089CrossRefGoogle Scholar
  20. 20.
    Danielsen SA, Eide PW, Nesbakken A et al (2015) Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta 1855:104–121Google Scholar

Copyright information

© Arányi Lajos Foundation 2019

Authors and Affiliations

  1. 1.Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  2. 2.Department of Colorectal Cancer SurgeryThe Second Affiliated Hospital of Harbin Medical UniversityHarbinChina

Personalised recommendations